Note: Rochester Clinical Research's revenues are gauged from an analysis of company filings.
Rochester Clinical Research's Income Statement (based on Industry Averages)
Rochester Clinical Research P&L
$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
Trademark Applications
Trademark applications show the products and services that Rochester Clinical Research is developing and marketing.
Rochester Clinical Research doesn't have any recent trademark applications, indicating Rochester Clinical Research is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
ADVANCING MEDICINE. CHANGING LIVES. Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs
01/25/2019
See all trademarks and details in the Full Report.
Market Share of Rochester Clinical Research's Largest Competitors
A competitive analysis shows these companies are in the same general field as Rochester Clinical Research, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Rochester Clinical Research.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Rochester Clinical Research and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.